Peter Maximilian Heil

554 total citations
19 papers, 352 citations indexed

About

Peter Maximilian Heil is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Biomedical Engineering. According to data from OpenAlex, Peter Maximilian Heil has authored 19 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Rheumatology and 6 papers in Biomedical Engineering. Recurrent topics in Peter Maximilian Heil's work include Photodynamic Therapy Research Studies (7 papers), Nanoplatforms for cancer theranostics (6 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Peter Maximilian Heil is often cited by papers focused on Photodynamic Therapy Research Studies (7 papers), Nanoplatforms for cancer theranostics (6 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Peter Maximilian Heil collaborates with scholars based in Austria, Germany and United States. Peter Maximilian Heil's co-authors include Georg Stingl, Dieter Maurer, Thomas Hultsch, R. Baumgärtner, Marc Dellian, A. E. Goetz, G. E. H. Kuhnle, Christoph Abels, Ronald Sroka and Jurina M. Wessels and has published in prestigious journals such as The Journal of Infectious Diseases, British Journal of Cancer and Journal of Investigative Dermatology.

In The Last Decade

Peter Maximilian Heil

19 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Maximilian Heil Austria 10 146 128 110 95 83 19 352
Robert H. Zax United States 8 111 0.8× 22 0.2× 93 0.8× 41 0.4× 74 0.9× 10 436
M. Vogelbruch Germany 7 165 1.1× 75 0.6× 28 0.3× 3 0.0× 46 0.6× 10 381
Rikke Bech Denmark 11 89 0.6× 12 0.1× 42 0.4× 8 0.1× 51 0.6× 22 603
Douglas J. Grider United States 13 31 0.2× 5 0.0× 81 0.7× 46 0.5× 55 0.7× 69 427
Giovanni William Oliverio Italy 13 35 0.2× 13 0.1× 59 0.5× 7 0.1× 10 0.1× 41 525
Johannes Schulte-Pelkum Germany 8 16 0.1× 21 0.2× 48 0.4× 12 0.1× 188 2.3× 14 371
H. Pillekamp Germany 10 115 0.8× 40 0.3× 33 0.3× 3 0.0× 208 2.5× 21 463
Francis Vaz United Kingdom 10 8 0.1× 12 0.1× 103 0.9× 35 0.4× 14 0.2× 23 480
Rami Archid Germany 12 25 0.2× 7 0.1× 103 0.9× 33 0.3× 12 0.1× 37 440
Bianka Sobolewska Germany 13 71 0.5× 6 0.0× 26 0.2× 6 0.1× 68 0.8× 32 456

Countries citing papers authored by Peter Maximilian Heil

Since Specialization
Citations

This map shows the geographic impact of Peter Maximilian Heil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Maximilian Heil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Maximilian Heil more than expected).

Fields of papers citing papers by Peter Maximilian Heil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Maximilian Heil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Maximilian Heil. The network helps show where Peter Maximilian Heil may publish in the future.

Co-authorship network of co-authors of Peter Maximilian Heil

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Maximilian Heil. A scholar is included among the top collaborators of Peter Maximilian Heil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Maximilian Heil. Peter Maximilian Heil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Karonitsch, Thomas, Roman Reindl‐Schwaighofer, Farsad Eskandary, et al.. (2025). Immunoadsorption as a novel therapy for refractory idiopathic inflammatory myopathies: a retrospective observational study. Lara D. Veeken. 64(10). 5304–5312. 1 indexed citations
2.
Heil, Peter Maximilian, Mark R. Pittelkow, Amy L. Weaver, et al.. (2024). Systemic correlates of cutaneous manifestations of lupus erythematosus. International Journal of Dermatology. 63(8). e148–e156. 1 indexed citations
3.
Gelpí, Ellen, Simon Hametner, Romana Höftberger, et al.. (2024). Impact of muscle biopsy on the clinical decision-making process in patients with suspected idiopathic inflammatory myopathy. Journal of Autoimmunity. 144. 103185–103185. 2 indexed citations
4.
Machold, Klaus, Hans P. Kiener, Daniel Bormann, et al.. (2022). COVID-19 as a putative trigger of anti-MDA5-associated dermatomyositis with acute respiratory distress syndrome (ARDS) requiring lung transplantation, a case report. BMC Rheumatology. 6(1). 42–42. 13 indexed citations
5.
Heil, Peter Maximilian. (2022). Leitfaden durch die Vielfalt des kutanen Lupus erythematodes. PubMed Central. 38(1). 32–39. 1 indexed citations
6.
Strobl, Johanna, et al.. (2021). Cutaneous ulceration as primary presentation of TEMPI syndrome. Journal of the European Academy of Dermatology and Venereology. 35(12). e891–e894. 5 indexed citations
7.
Derhaschnig, Ulla, Christian Schoergenhofer, Christa Firbas, et al.. (2019). Specific Inhibition of the Classical Complement Pathway Prevents C3 Deposition along the Dermal-Epidermal Junction in Bullous Pemphigoid. Journal of Investigative Dermatology. 139(12). 2417–2424.e2. 26 indexed citations
8.
Payer, B.A., Thomas Reiberger, F Breitenecker, et al.. (2012). The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV. Journal of Infection. 65(2). 142–149. 10 indexed citations
9.
10.
Heil, Peter Maximilian, et al.. (2010). Omalizumab‐Therapie atopischer Dermatitis: IgE‐Depletion führt nicht zur klinischen Besserung – eine randomisierte, placebo‐kontrollierte, doppelblinde Pilotstudie. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 8(12). 990–999. 12 indexed citations
11.
Heil, Peter Maximilian, et al.. (2010). Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course – a randomized, placebo‐controlled and double blind pilot study. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 8(12). 990–998. 147 indexed citations
12.
Heil, Peter Maximilian, Beatrix Volc‐Platzer, Franz Karlhofer, et al.. (2005). Transglutaminases as diagnostically relevant autoantigens in patients with gluten sensitivity. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 3(12). 974–978. 11 indexed citations
13.
Heil, Peter Maximilian, Susanne Stocker, Ronald Sroka, & R. Baumgärtner. (1997). In vivo fluorescence kinetics of porphyrins following intravesical instillation of 5-aminolaevulinic acid in normal and tumour-bearing rat bladders. Journal of Photochemistry and Photobiology B Biology. 38(2-3). 158–163. 15 indexed citations
14.
Abels, Christoph, Peter Maximilian Heil, Marc Dellian, et al.. (1994). In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster. British Journal of Cancer. 70(5). 826–833. 62 indexed citations
15.
Sroka, Ronald, et al.. (1994). <title>Is the photobleaching signal a useful tool for dosimetry during photodynamic therapy?</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 2078. 422–426. 1 indexed citations
16.
Baumgartner, Reinhold, M. Kriegmair, Ruth Knuechel, et al.. (1994). <title>Delta-ALA-assisted fluorescence detection of cancer in the urinary bladder</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 2081. 74–80. 7 indexed citations
17.
Wessels, Jurina M., Ronald Sroka, Peter Maximilian Heil, & Harald K. Seidlitz. (1993). Photodegradation of Protoporphyrin-dimethylester in Solution and in Organized Environments. International Journal of Radiation Biology. 64(5). 475–484. 18 indexed citations
18.
Baumgartner, Reinhold, M. Kriegmair, Herbert Stepp, et al.. (1993). <title>Photodynamic diagnosis following intravesical instillation of aminolevulinic acid (ALA): first clinical experiences in urology</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 1881. 20–25. 7 indexed citations
19.
Baumgartner, Reinhold, et al.. (1991). <title>Improved instrumentation for photodynamic fluorescence detection of cancer</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 1525. 246–248. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert H. Zax Breakdown of academic impact, for papers by M. Vogelbruch Breakdown of academic impact, for papers by Rikke Bech Breakdown of academic impact, for papers by Douglas J. Grider Breakdown of academic impact, for papers by Giovanni William Oliverio Breakdown of academic impact, for papers by Johannes Schulte-Pelkum Breakdown of academic impact, for papers by H. Pillekamp Breakdown of academic impact, for papers by Francis Vaz Breakdown of academic impact, for papers by Rami Archid Breakdown of academic impact, for papers by Bianka Sobolewska
Rankless by CCL
2026